Randomization and placebo effects in clinical trials of major depressive disorder
Saved in:
Main Authors: | James A. Rogers, Stephen Senn |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-025-03263-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beneficial and harmful effects of duloxetine versus placebo, ‘active placebo’ or no intervention for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
by: Christian Gluud, et al.
Published: (2025-02-01) -
Effect of vortioxetine versus venlafaxine on cognitive functions in adults with major depressive disorder: A randomized-controlled trial
by: Chayan K. Manna, et al.
Published: (2023-08-01) -
Glucose metabolism impairment in major depressive disorder
by: Fanhao Meng, et al.
Published: (2025-02-01) -
The effect of probiotic-fortified kefir on depression, appetite, oxidative stress, and inflammatory parameters in Iranian overweight and obese elderly: a randomized, double-blind, placebo-controlled clinical trial
by: Mehran Noori, et al.
Published: (2025-02-01) -
Effect of remote ischemic preconditioning on perioperative neurocognitive disorder in elderly patients undergoing major surgery and associated genetic variant analysis: a randomized clinical trial
by: Feifei Xu, et al.
Published: (2025-02-01)